A2 DISCOVER

Serial Number 88302481
606

Registration Progress

Application Filed
Feb 14, 2019
Under Examination
Feb 11, 2020
Approved for Publication
Dec 17, 2019
Published for Opposition
Dec 17, 2019
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: A2 DISCOVER
Previous Owner: A2 Biotherapeutics, Inc.
Classes: 005, 042

Trademark Image

A2 DISCOVER

Basic Information

Serial Number
88302481
Filing Date
February 14, 2019
Published for Opposition
December 17, 2019
Abandonment Date
March 14, 2022
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 14, 2022
Classes
005 042

Rights Holder

A2 Biotherapeutics, Inc.

03
Address
30301 Agoura Road, Suite 210
Agoura Hills, CA 91301

Ownership History

A2 Biotherapeutics, Inc.

Original Applicant
03
Agoura Hills, CA

A2 Biotherapeutics, Inc.

Owner at Publication
03
Agoura Hills, CA

Legal Representation

Attorney
Joi A. White

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

29 events
Date Code Type Description Documents
Mar 14, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Mar 14, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jul 17, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 15, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jul 15, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Jul 15, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 4, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 2, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 2, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 2, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 22, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 20, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 20, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 20, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 11, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 17, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 17, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 27, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 14, 2019 ALIE A ASSIGNED TO LIE Loading...
Nov 12, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 2, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 1, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 1, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 2, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 2, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 2, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 25, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 8, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 18, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
T-cell pharmaceutical products for the treatment of cancer; therapeutic targets, namely, proteins or protein complexes, for the treatment and prevention of cancer; therapeutic cells, for medical use, for the treatment and prevention of cancer; therapeutic proteins and therapeutic antibodies, for medical use, for the treatment and prevention of cancer in humans; therapeutics and cellular therapies in the nature of proteins and protein complexes for the treatment of cancer; biologics, namely, proteins and protein complexes for in-vitro diagnostic use for the treatment of cancer
Class 042
Provision of, and identification and development of, therapeutic targets, namely, proteins and protein complexes, for others for the treatment and prevention of cancer; development of therapeutics and cellular therapies, namely, pharmaceutical, biological and medical therapies for the treatment of cancer; biotechnology research, development, testing and analysis for the treatment of cancer; Scientific research and development services; providing scientific information in the fields of treatment and prevention of cancer

Additional Information

Pseudo Mark
A TWO DISCOVER

Classification

International Classes
005 042